Phase I and pharmacokinetic study of UCN-01 and fludarabine in relapsed or refractory low-grade lymphoid malignancies

Trial Profile

Phase I and pharmacokinetic study of UCN-01 and fludarabine in relapsed or refractory low-grade lymphoid malignancies

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Sep 2007

At a glance

  • Drugs Fludarabine (Primary) ; UCN 01
  • Indications Chronic lymphocytic leukaemia; Follicular lymphoma; Hairy cell leukaemia; Lymphoma; Mantle-cell lymphoma; Waldenstrom's macroglobulinaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Feb 2007 Status change to no longer recruiting
    • 07 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top